Initially identified as a positive regulator of mitochondrial apoptosis, AIFM2 translocates from mitochondria to the plasma membrane in GPX4-low-expressing cancer cells when stimulated with ferroptosis inducers (e.g., RSL3 and ML162) [107, 108]. Here, AIFM2 is linked to cancer.